#Pressure Ulcer Companies

[stevenwilliam12]

Projected Expansion of the Pressure Ulcer Market by 2032

The pressure ulcer market is poised for significant growth by 2032, with key players such as Phagelux, MiMedx, EyeGene, Shionogi, NovaLead Pharma, Smith & Nephew PLC, Integra LifeSciences, Baxter International, Molnlycke Health Care AB, Cardinal Health, Essity Aktiebolag, 3M Company, B. Braun Melsungen, ConvaTec Group, and Coloplast Group expected to drive this transformation. A comprehensive report by DelveInsight, titled “Pressure Ulcer Market Insight: Epidemiology and Market Forecast, 2032,” aims to assist companies in developing effective therapies for pressure ulcers.

Key Insights from the Pressure Ulcer Market Report

The pressure ulcer market is projected to expand significantly across the seven major markets (7MM) during the study period.

The incidence of pressure ulcers is notably higher among patients with diabetes. Of the 537 million adults with diabetes in the 7MM, around 150 million are likely to suffer from ulcers at some point in their lives.

Research indicates that approximately 10% of individuals in the United States will experience pressure ulcers during their lifetime.

The market is expected to surge due to the increasing prevalence and awareness of pressure ulcers, along with the introduction of new products that will alter market dynamics.

Get a free sample of “Pressure Ulcer Market Report”

Treatment Approaches and Analysis

The report offers an in-depth examination of treatment protocols across the 7MM, helping companies to analyze current practices, patient journeys, and advances in therapies for pressure ulcers. This analysis is crucial for identifying innovative treatment options that can enhance patient outcomes.

Understanding Pressure Ulcers

Pressure ulcers, commonly referred to as bedsores or pressure sores, are localized injuries to the skin and underlying tissues resulting from prolonged pressure. They typically develop in individuals who are bedridden, use wheelchairs or have limited mobility, usually occurring over bony areas like the heels, hips, tailbone, and elbows. Several factors, including pressure intensity, duration, and the individual’s overall health, influence their development. Effective prevention includes regular repositioning, maintaining proper nutrition, utilizing specialized support surfaces, and ensuring good skincare. Timely detection and appropriate management are vital for preventing complications and promoting healing.

Get a free sample of “Pressure Ulcer Market Report”

Epidemiological Insights

The report provides historical and forecasted epidemiological data, allowing stakeholders to understand the target patient population for pressure ulcers. The analysis covers trends from 2019 to 2032, segmented by total prevalence, severity, gender-specific prevalence, and diagnosed cases, facilitating in-depth insights into patient demographics.

Emerging Therapies and Market Dynamics

Anticipated launches of new therapies, such as Thymosin Beta 4 and Ibuprofen, are expected to reshape the pressure ulcer market in the coming years. The rising prevalence of diabetes, increasing awareness of pressure ulcers, and a shift in focus among companies, despite the low awareness of the condition, are driving market growth.

Strategic Decision-Making and Opportunities

DelveInsight's report provides essential insights to aid leading companies in making informed strategic decisions regarding the pressure ulcer market. Understanding the competitive landscape, and key players in drug development, and identifying market gaps allows stakeholders to position themselves effectively and capitalize on emerging opportunities.

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm focused on life sciences. It provides comprehensive end-to-end solutions for pharmaceutical companies, including healthcare consulting services that enhance market analysis and support business growth.

In summary, the pressure ulcer market is on track for substantial growth by 2032, driven by increased awareness, innovative therapies, and strategic initiatives by key companies. Stakeholders are encouraged to utilize insights from DelveInsight's report to navigate this evolving landscape successfully.

Latest Reports

Prader-willi Syndrome Market | Progressive Supranuclear Palsy Market | Scleroderma Market | Vernal Keratoconjunctivitis Market | Acquired Immunodeficiency Syndrome Market | Acute Intermittent Porphyria Market | Acute Pharyngitis Market | Acute Radiation Syndrome Market | Airway Stent Market Market | Alopecia Areata Market | Anti-cd274 Pd-l1 Antibody Pipeline | Apheresis Market | Artificial Lung Devices Market | Bacteremia Market | Biliary Tract Cancer Market | Bladder Pain Syndrome Market | Brain/cranial Implants Market | Capnography Device Market | Cardiac Amyloidosis Market | Catheter-related Bloodstream Infections Market | Cervical Intraepithelial Neoplasia Market | Chronic Obstructive Pulmonary Disease Market | Chronic Pruritus Market | Cluster Headache Market | Dermal Mycosis Market | Duchenne Muscular Dystrophy Market | Emesis Market | Foot And Ankle Devices Market | Gout Market | Graft Versus Host Disease Market | Head And Neck Cancer Market | Healthcare Competitive Intelligence

[scotianostra]

The pharmacologist James Whyte Black was born on 14th June 1924, in Uddingston, Lanarkshire.

During his lifetime James Black was involved in the development of two different treatments, Propranolol, (Inderal) a beta blocker used to treat high blood pressure and Cimetidine ( Tagamet), used for heartburn.

He attended Beath High School where his teacher persuaded him to take the competitive entrance examination for St Andrews University. An intelligent boy, he managed to earn the Patrick Hamilton Residential Scholarship. Going on to study medicine but decided against a career as a doctor instead going on to lecture at University College before moving to Singapore and then back to University of Glasgow

It was in Glasgow Blacko built a research laboratory providing the most advanced cardiovascular technology and developed an interest in the effects of the hormone adrenaline on the human heart.

He was persuaded to leave the academic life and joined ICI Pharmaceuticals in 1958. His years with the company led to some extraordinary discoveries in medical science. He collaborated with scientists in his team to develop propranolol which is a beta blocker used for the treatment of heart disease. The discovery of propranolol is considered one of the greatest breakthroughs in the treatment of heart disease.

Along with the development of propranolol, Black was also working on developing a similar method of treatment for stomach ulcers. However, ICI was not interested in pursuing research in this direction. Thus, Black resigned in 1964 and joined Smith, Kline and French, it was with them he developed a new drug called cimetidine, now you might not have heard of it by that name but the company branded it as Tagamet in 1975, used in the treatment of heartburn and peptic ulcers it became the world’s largest-selling prescription drug.

Black was knighted in 1981 and was awarded the 1988 Nobel Prize in Medicine along with Gertrude B. Elion and George H. Hitchings “for their discoveries of important principles for drug treatment.”

In 2006 Dundee University honoured him with the opening of the Sir James Black Centre, the following year King’s College London followed Dundee by also opening a centre named after Black.

Black died, aged 85, on the morning of 22nd March 2010 after a long illness and is buried at the Ardclach cemetery near Nairn. Upon hearing of Black’s death, Professor Pete Downes, Principal and Vice-Chancellor of the University of Dundee said Black “was a great scientist, but he was also a great man to know” while the BBC said he was “hailed as one of the great Scottish scientists of the 20th Century”. He was described by The Daily Telegraph as the man who earned the most for the pharmaceutical industry through his drug development, though he received little personal financial gain from his work.

[rabbitcruiser]

National Banana Lovers Day

Today we celebrate the banana—the most popular fruit in the United  States and around the world. The average person eats about 100 of them a  year, which comes out to about 25 to 33 pounds worth. They are the  cheapest fruit and are also one of the most perishable. They may appear  to grow on trees, but they actually grow on plants that have 10 to 20  feet high trunks. The banana plant is an herb—the largest herb plant,  actually—and bananas are its fruit. The plant grows in the tropics.

Each banana is about 100 calories and is high in fiber and potassium,  which are good for treating high blood pressure, ulcers, calcium loss,  and some cancers. Bananas are also a good source of manganese, vitamin  B6, and vitamin C. There are over 1,000 varieties of bananas, but the  kind most eaten in the United States is the Cavendish. The Gros Michel  was once the most commonly eaten, but in the 1950s it fell victim to a  fungus that causes Panama disease, so farmers had to switch to the  Cavendish.

Bananas are the oldest cultivated fruit and likely were first  domesticated in Southeast Asia. Centuries later, shortly after Europeans  arrived in the Western Hemisphere, they were brought from the Canary  Islands to Hispaniola. They then spread to other islands, before making  it to the mainland. They didn't become widespread in the United States  until the end of the nineteenth century. They were so popular in  American cities in the early twentieth century that banana peels on the  ground became a nuisance and an issue that had to be dealt with. This  led to the gag of slipping on banana peels, which was frequently  featured in early movies.

Bananas were popularized in part by the United Fruit Company, which  was founded in the late nineteenth century, and is now known as  Chiquita. They encouraged people to eat bananas with milk and corn  flakes, and they put out banana recipe books until the end of the 1950s.  The books oftentimes contained adventurous recipes and aimed to get  people to eat bananas at every meal. They cast the banana not only as  something sweet but also as something similar to a vegetable, like a  potato. One example of a recipe from the book is ham banana rolls with  cheese sauce. Nowadays, bananas are still eaten in many different ways.  Besides being enjoyed plain, they may be fried, may be included in  sandwiches, and may be used in pies, puddings, muffins, breads, and  cakes—among other things. On National Banana Lovers Day, the sky's the  limit as to what can be done with them!

How to Observe National Banana Lovers Day

You should be eating as many bananas and foods made with bananas as possible today. While doing so, perhaps you could read Banana: The Fate of the Fruit That Changed the World. You could pick up an old United Fruit/Chiquita recipe book to help you decide what to eat, but we have also put together some recipe ideas for you here as well:

Elvis Presley's fried peanut butter and banana sandwich

Grilled banana s'mores

Fried sweet bananas

Honey-rum grilled bananas

Eat bananas with corn flakes and milk, just as United Fruit once encouraged everyone to do.

Try bananas in milk, with a little bit of sugar and a few drops of vanilla extract.

Banana bread

Banana muffins

Banana cake

Banana split

Banana cream pie

Banana pudding

Banana cocktails

Banana smoothies

Make some matooke, which is the most popular banana dish in the world and from Uganda.

Make Bananas Foster, a New Orleans specialty.

Make the original United Fruit ham banana rolls with cheese sauce!!!

Source

[herecirmsims]

15 Questions Tag Game

Thank you @alpine-lapine​​ for the tag! I’ll put the questions and answers below a cut so as not to clog the timeline. Random story screenshot above, just because.

Are you named after anyone? Yeah, a person my mum met while backpacking during her gap year.

When was the last time you cried? I stabbed myself in the eye a few weeks ago on some rush grass, I cried then. It left an ulceration across my cornea (which apparently has the most nerves in the eye?) and was UNBELIEVABLY painful. I spent a couple days unable to see because moving the damaged eye (which I couldn’t open anyway) meant it rubbed against my eyelid and hurt like hell, and I had to keep my good eye closed to avoid the temptation to move my eyes to look at things. I don’t recommend, tbh.

Do you have kids? Absolutely not.  😅

Do you use sarcasm a lot? Not really. I s’pose I might be peak British and say “Oh yeah it was fucking amazing” if someone asks how a bad situation went.  🤔 I enjoy sarcasm when I understand it/know the person using it, but otherwise it stresses me out when people say things they don’t mean.

What sports do you play/have you played? None competitively, I don’t really enjoy them.

What’s the first thing you notice about other people? Their energy, which is the most hippyish response I could’ve said.  🤣

Eye colour? Blue-grey, somewhere in between.

Scary movies or happy endings? Happy endings! I enjoy a lot of angst on the way there, though. The angst makes the happy ending sweeter, I think, but I like to know that it will end well. Nothing worse than investing myself in a story only to be left feeling sad and empty at the end of it.

Any special talents? Hmm... no. I’m quite good at finding things - noticing small insects or interesting things amongst the stones at the beach, stuff like that.

Where were you born? In the UK.

What are your hobbies? The vast majority of my hobbies are Sims related - storytelling, posemaking, playing. I also enjoy looking for old bottles in Victorian dumps (a lot of farms have them round here), looking for cool things on the beach, bug-hunting, growing vegetables, archery, writing fantasy, hiking.

Do you have any pets? Yes! I have a cat (an ex feral kitten) called Belleraphon or Bel for short, two ponies called Cash and Joey (though they’re really my partners. One was bought because he was going through sales, and with his issues my partner knew he’d have a bad outcome - he’s not ridden and lives in retirement with us. The other was given to us for free by a roofer we had in, and we took him because he’d been living on his own for four years - equines absolutely need company), and two mules called Marty and Xato who are mine (my own! My precious! I bought one for £1 and the other was given to me. I don’t talk about them much in my Sims community circles but I’m obsessed with them... mules are absolutely my number one special interest).

How tall are you? 5′3″

Fave subject in school? English and Media Studies

Dream job? I'd still say author, though whether I’ll ever get over my perfectionist trait and publish anything is another issue. I enjoy writing drabbles for myself, and I enjoy my Sims story which is god-awful but I embrace that - it’s been really freeing just to put down whatever I want to read, and share without overthinking anything. It would be nice to earn money from things I enjoy, but that then puts pressure on them.

I’m not tagging anyone because I tarried and I think everyone who I would’ve tagged has done this already, so if you see this then it’s an open invitation. 

And because I think people might ask, and I can’t resist talking about them a teeny tiny bit... here are my mules. Marty, on the left, was photographed here on his way to the shops; Xato, on the right, was helping me carry sacks of pulled hemlock up to the bonfire. Marty is my going out and about mule (he also does litter-picking, takes bottles to the recycling centre, carries food and luggage on long hikes), and Xato is the work-on-the-farm mule. Though neither have done much at all for a while because sometimes I’m not very good at walking.  😅 

[honeyriot]

Building a Porn Empire

Playboy was an overnight success story, with circulation growing from 53,991 in its first month (December 1953) to 175,000 by its first anniversary issue. By 1959 Playboy had a monthly circulation of 1 million. In its heyday of the late 1960s and early 1970s, Playboy was an enormous company, with sales of over $200 million and more than five thousand employees. 2 Clearly, as Michael Kimmel argues, “ Playboy struck a nerve with American men,” and many books have attempted to describe exactly what that nerve was. 3 To explore the Playboy phenomenon and the magazine’s role in laying the groundwork for the contemporary porn industry, the magazine has to be historically located in the economic and cultural trends at work during the 1950s, which at different times and to varying degrees contributed to Playboy becoming the lifestyle-pornographic magazine of choice for the upwardly mobile, white American male in the postwar years. Historians agree that the 1950s were a time of enormous change in the United States, both economically and culturally. They point to the economic boom, the baby boom, the growth of suburbia, the pressure to marry at an early age, and the push toward consumption as a way of life as trends that, while not being specific to the 1950s, were nonetheless magnified in that decade. 4 Playboy occupied an ambivalent place in relation to these trends—it celebrated celebrated some as good for the country while condemning others as harmful to American men. It was its uncanny ability to pick and choose among these trends that made Playboy a success not only with readers but also, eventually, with advertisers. Hefner was clear about his target audience from the very beginning. He wrote in the first issue of Playboy, published in December 1953: “If you are a man between 18 and 80, Playboy is meant for you. . . . We want to make it clear from the start, we aren’t a ‘family’ magazine. If you are somebody’s sister, wife or mother-in-law and picked us up by mistake, please pass us along to the man in your life and get back to the Ladies’ Home Companion. ” For a magazine to clearly state that it was not “a family magazine” in the 1950s was close to heresy. According to social historian Stephanie Coontz, it was during this period that there was an unprecedented rise in the marriage rate, the age for marriage and motherhood fell, fertility increased, and divorce rates declined. From family restaurants to the family car, “the family was everywhere hailed as the most basic institution in society.” The print media also got in on the act, carrying stories about the supposed awfulness of being single. Reader’s Digest ran a story entitled “You Don’t Know How Lucky You Are to Be Married,” which focused on the “harrowing situation of single life.” One writer went so far as to suggest that “except for the sick, the badly crippled, the deformed, the emotionally warped and the mentally defective, almost everyone has an opportunity to marry.” In the 1950s, “emotionally warped” was a coded way of saying homosexual, and indeed many single people were investigated as potential homosexuals and by extension Communists, since the two were often linked during the McCarthy years. Probably one of the most woman-hating books of the time was Philip Wylie’s Generation of Vipers, first published in 1942 and reprinted after World War II. For Wylie, wives were the cause of men’s problems because they controlled the home with an iron fist and worked their spouses to death in order to enjoy a life of leisure. As Wylie so eloquently put it, “It is her man who worries about where to acquire the money while she worries about how to spend it, so he has the ulcers and she has the guts of a bear.” It was during these woman-hating, pro-family years that Playboy hit the newsstands. Picking up on the themes of the 1950s, Playboy editors, from the very first issue, defined single women as menaces to the Playboy reader since they were out to trap him into marriage and bleed him financially. Indeed, the first major article in the first issue of Playboy was called “Miss Gold-Digger of 1953.” Bemoaning the good old days when alimony was reserved for “little floosies,” Playboy editors wrote, “When a modern day marriage ends, it doesn’t matter who’s to blame—it’s always the guy who pays and pays and pays and pays.” Echoing Wylie’s assertion that women had taken over America, the article continued, “A couple of generations ago, this was a man’s world, nothing could be further from the truth in 1953.”

Playboy was not the only media product to sell the 1950s young adult an ideology of consumption. According to historian George Lipsitz, the main function of television in the 1950s was to provide “legitimation for transformations in values initiated by the new economic imperatives of postwar America.” One way to do this, according to Ernest Dichter, the marketing guru of the 1950s, was to demonstrate “that the hedonistic approach to life is a moral one, not an immoral one.” While Playboy was one of many media corporations to employ Dichter, it was one of a few whose clear aim was to turn the male into a consumer. Elaine May has argued that the 1950s was in general the period of the “expert,” where increasing numbers of people turned to professionals for advice on just about every aspect of life, from what to buy to how to prepare for a nuclear war. Playboy editors certainly played the role of expert, telling readers “what to wear, eat, drink, read and drive, how to furnish their homes and listen to music, which nightclubs, restaurants, plays and films to attend, what equipment to own.” However, as with all advertising, the actual product on offer was not the commodity being advertised but rather the fantasy of transformation that this product promised to bring to the consumer’s life. The high-quality products shown in Playboy would transform the reader into a “playboy” who could then have the real prize: all the high-quality women he wanted—just like the ones who populated the magazine. The women in the Playboy pictorials were designed to be “teasers,” demonstrating to the reader what he could have if he adopted the Playboy lifestyle of high-level consumption. In an interview, Hefner revealed this strategy of sexualizing consumption when he explained: “ Playboy is a combination of sex . . . and status . . . the sex actually includes not only the Playmate and the cartoons and the jokes which describe boy-girl situations, but goes right down in all the service features.” Hefner, by sexualizing consumption, provided an extremely hospitable environment for advertisers looking to expand markets in the postwar boom. By the end of 1955, advertisers had overcome their initial fear of advertising in a “men’s entertainment” magazine and were, according to Weyr, “clamoring to buy.” During the 1950s and 1960s, Playboy continued to increase its readership and its advertising revenue, and by the late 1960s the circulation figures reached an all-time high of 4.5 million. An article in Business Week in 1969 entitled “ Playboy Puts a Glint in the Admen’s Eyes” discussed the enormous popularity of Playboy magazine with advertisers, quoting a media man at J. Walter Thompson Company, the world’s largest advertising agency at the time, saying that years ago none of their clients would have touched Playboy but “today, it’s a routine buy.” The magazine then informed its readers that “last year JWT expenditure in the magazine increased 70%.” Despite the increased advertising revenue that Playboy enjoyed well into the 1960s, its relationship with advertisers was stormy. The main reason for this was Playboy’s somewhat split personality as both a lifestyle magazine and a porn publication. According to Weyr, the advertisers liked Playboy ’s readership (mostly white, college-educated, upwardly mobile men) yet disliked its sexual content for fear of being associated with a sleazy porn magazine. In the early years, Hefner and his major associates regularly flew to New York for emergency meetings with advertisers whose clients felt that the pictorials or stories had become too explicit. Many of these meetings ended in a promise from the Playboy staff to limit the overt sexual content and no revenue was lost. One such battle occurred over a story by Calder Willingham that appeared in the July 1962 issue. Called “Bus Story,” it focuses on the rape of a seventeen-year-old girl by an older man. However, as in much of pornography, the story is written in a way that sexualizes the brutality: “There are times to be tender and times to be just a little rough. This was a time to be just a little rough. Left forearm heavily across her breasts and left hand gripping her shoulder so hard she winced, Harry used his knees like a wedge, grey eyes hypnotic above her. ‘Open your legs,’ he said in a cold, hard and vicious tone. Lips apart and eyes empty with shock, the girl did as she was told. A moment later, hands limp on his shoulders, a gasp came from her. Then another gasp.” According to Weyr, a number of companies, including Ford Motor, threatened to cancel contracts with Playboy and a number of newsstand wholesalers refused to carry the July issue. Fear of losing the advertisers prompted Hefner to write a letter of apology to all the major corporations who advertised in the July issue, and he offered to meet personally with their representatives. This kind of economic power meant that advertisers policed (and continue to police) the sexual content of Playboy. Thus, built into the magazine was a conflict between the need to attract advertising revenue and the need to keep readers interested by publishing sexual content.

[bjfinn]

How is it four years already?

My da was born in Little Burgundy in 1926, the third of eleven children. His father was an abusive alcoholic piece of shite who liked to beat his sons, and my da, the second oldest boy, was never spared his wrath. Despite this, my da was a good man, and, unlike every one of his brothers and sisters, was normal and well-adjusted - he worked at the same company for nearly forty years until his retirement, didn't drink to excess, never cheated on his wife, never raised a hand to his children ...

For most of my life, he pretty much ignored me, but I'm sure - I know without a doubt - that was because he was afraid he would be the same kind of father that he had had - he loved me so much that he kept me at arm's length. And, yes, I'll admit that I resented him for it. But on Sundays (after he'd retired), when he allowed himself four beers, and on special occasions like Christmas, that was when he let himself spend time with me, telling me stories of his childhood, listening to music and watching movies with me. Those were the times when I saw who he really was.    

Even after my ma died, he kept his distance. It was only when he was diagnosed with cancer in 2015, and everyone thought he would soon be gone - afterwards, when he recovered, when the cancer went into remission, he realised that I had devoted myself fully to caring for him, that I loved him, and that was when he finally allowed himself to show me that he truly did love me.  

In January of 2018, on the last Wednesday of the month, he fell and broke his hip. He was getting up from the couch to change his trousers in preparation for the arrival of my sister and her husband, and I guess he moved a little too fast and lost his balance. I ran in to see him lying on his side on the carpet, and I hauled him up and got him back on the couch. Then I called 911. My sister and brother-in-law arrived, and we waited two hours for the ambulance to take him to hospital. 

The next morning, they took him to surgery and put two pins in his hip. He was two weeks in hospital, and then he was transferred to the rehab centre in Crawford Park. He was there for six weeks, learning how to walk again, and the staff were amazed at his progress - I was, too, but I knew that he wanted to make me proud of him. I spent most of every day of those eight weeks with him, and when I wasn't there, my sister and brother-in-law were.  

After that, he needed a walker to get around, but with it he could move just as fast as before - when we brought him home, he was halfway up the stairs before I knew it. 

He loved music, though he couldn't play an instrument. He had a wonderful singing voice, though, and could whistle beautifully.  

He loved food, though he couldn't cook.

He loved movies and TV.

He loved professional wrestling.  

He was a good husband and father. 

He was a good man. 

He was the strongest man I've ever known.

He was my hero.

He was my best friend, and I'm a better person for having had him for my father.

Then one morning, I went into his room to wake him up, but he was almost completely unresponsive. Eventually I got him into the kitchen and seated at the table for breakfast - he ate it all, and then said that he needed to go to the toilet. I helped him up, or tried to - he couldn't stand by himself, so I had to half-carry, half-drag him to the bathroom, during which time his bowels let go and thick, black, tarry shit was everywhere. I knew it was an ulcer - when I was very young, I woke up one morning to find him puking up black blood in the bathroom. I got him on the toilet and called 911. Again.

The ambulance arrived minutes later, and the paramedics said that his blood pressure was dangerously low. They stabilised him and rushed him to hospital. I rode with him in the back of the ambulance. 

At the hospital, the doctors biopsied the ulcer, and five days later he came home. It was a full two weeks - fourteen days - when they got the results of the biopsy. The cancer had come back, and had spread throughout his body. There was no hope.  

I devoted myself fully to caring for him, watching him become progressively weaker and weaker until he was confined to his bed, unable to eat solid food, unable to speak - all he could do was smile, and tell me he loved me with his eyes. My da became my baby boy, and showed me what it would've been like to be a father - his final gift to me.

He died on 23 June 2019, at 5:30 pm, in his own bed. In his own home.

I miss him so much, every minute of every day. Why did he die? Why did he have to leave me, just as we had finally become close?

Maybe there's an afterlife, and I'll see him again someday. Until then, I'll cry an ocean of tears for him.

I'll never ever forget him. Ever.

I love you, Da. Now and forevermore.💔

[healthcare-domain]

Compression Therapy Market Regional Trends, Growth Projection and Global Industry Analysis Report

Increasing large target patient population and the rising incidence of sports injuries and accidents are the major factors driving the growth of this market. Moreover, strong focus of players in expanding their product offerings in compression therapy is anticipated to support the growth of the market. However, poor patient compliance for compression products is expected to restrain the growth of this market during the forecast period.

Globally, an increasing number of people are actively participating in sports and physical activities (as a result of the growing awareness about health and fitness). This trend has, in turn, increased the incidence of sports injuries and injuries related to other physical fitness activities. In the US alone, ~8.6 million sports injuries are registered annually (Source: US Department of Health and Human Services, data as of 2021).

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=146548022

Patient non-compliance to compression products and non-adherence to treatment protocols are the common issues related to compression therapy. The non-compliance rate increases particularly in long-term treatments, where the primary aim is to prevent the occurrence of a specific condition (such as the occurrence/reoccurrence of ulcers). Since compression therapy is generally used as a preventive therapy in a majority of cases, the compliance rate of patients to the therapy decreases over time. Moreover, conditions such as pain, swelling, and skin irritation are associated with the regular use of compression garments.

Increasing sales of compression products through e-commerce websites and off-the-shelf channels across mature markets are expected to offer significant growth opportunities for the manufacturers of compression therapy products.

Compression bandages are the first line of treatment of venous diseases and are used to prevent their recurrence during compression therapy. The increasing prevalence of diabetes and the rising geriatric population prone to venous ulcers, foot ulcers, varicose veins, edema and growing availability of compression bandages in the market are  expected to support the growth of the compression bandages market during the forecast period.  

Rapid growth in the geriatric population, rising number of orthopedic and spinal surgeries, and the presence of various compression therapy product manufacturers in the region. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the rapid expansion of the target patient population in several Asia Pacific countries.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=146548022

Compression Therapy Market Dynamics:

Drivers:

Large target patient population

Growing incidence of sports injuries and accidents

Increasing number of orthopedic procedures

Greater product affordability and market availability

Clinical evidence favoring adoption of compression therapy for management of target conditions

Restraints:

Lack of universally accepted standards for compression products

Low patient compliance with compression garments

Opportunities:

Growth potential offered by emerging markets

Growing patient awareness regarding benefits of compression therapy

Increased sales of off-the-shelf and online products

Direct-to-consumer orthodontics

Challenges:

Significant adoption of alternative therapies for specific target indications

Increasing pricing pressure on market players

Key Market Players:

The major players operating in the global compression therapy market are DJO Global, Inc. (US), BSN medical (US), medi GmbH & Co. KG (Germany), Tactile Medical (US), SIGVARIS (Switzerland), Paul Hartmann AG (Germany), Sanyleg S.r.l. (Italy), 3M Company (US), ConvaTec Inc. (US), ArjoHuntleigh (Getinge Group, Sweden), and Julius Zorn GmbH (Germany)

[market-insider]

Market Report on Varicose Veins Treatment: Understanding Size, Share, Growth Trajectories

The global varicose veins treatment market size is expected to reach USD 2.08 billion by 2030, registering to grow at a CAGR of 6.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. The increasing technological advancements coupled with the increased availability of the advanced varicose vein treatment devices and shift towards less-invasive procedures are the contributing factors for the growth of the market. 

Varicose Veins Treatment Market Report Highlights

The sclerotherapy segment was identified as the most profitable procedure owing to the benefits, such as the requirement of minimal incision and reduced scarring, related to the procedure. Moreover,the following advantages: increased penetration, cost and time efficiency, reduced risk of collateral damage to surrounding tissues, fewer post-operative complications, and painless procedure are the main contributors for the growth of this segment.

The endovenous ablation segment is expected to be the fastest growing segment due to the benefits of short treatment time and improved blood circulation after the procedure. The ClosureFast technique in the endovenous ablation treatment segmenthas gained momentum due to the minimized side effects, potential cost-saving ability, and better patient outcomes.

The endovenous chemoablation or chemical sclerosis segment was the most widely used medical procedure among the ablation procedures. Sclerotherapy, intense-pulsed-light therapy, laser ablation, radiofrequency, and ambulatory phlebectomy are the modern techniques that are usedmore oftendue to their less invasive nature.

In 2023, North America held the largest market share due to the increasing incidence rate of varicose and spider vein in the population, favourable reimbursement policies, increased healthcare awareness, government spending, and the rising aesthetic awareness in the region

The Asia Pacific is expected to register the fastest growth due to factors, such as the improving healthcare infrastructure, the increase in patient awareness level regarding the benefits of early treatment of the varicose veins, and the rising disposable income

For More Details or Sample Copy please visit link @: Varicose Veins Treatment Market Report

The huge burden of vascular diseases in Europe and North America and the increasing patient compliance and reliability, growth in healthcare expenditure, and the rapid growth in geriatric population is majorly driving the varicose vein procedure market. 

The upward trend in lifestyle disorders, such as increasing obesity, sleep disorders, blood pressure levels, hormonal changes, genetic disorders and pregnancy are the few major factors contributing to the peripheral vascular diseases. Untreated venous insufficiency, such as varicose vein and venous ulcers cause progressive syndromes including chronic veinous insufficiency. In 2015, according to FutSci, chronic veinous insufficiency is widespread and is a socially isolating condition caused in adults. It is the most common disease in the world and is estimated to affect 5% of the population in the Western countries. 

List of major companies in Varicose Veins Treatment Market

Medtronic

Lumenis Be Ltd.

AngioDynamics

Sciton

Quanta System

intros Medical Laser GmbH

Alma lasers

For Customized reports or Special Pricing please visit @: Varicose Veins Treatment Market Report

We have segmented the global varicose vein treatment market based on type, end-use and region.

[blogofmastermind]

Navigating the World of Home Healthcare Equipment: CPAP Machines, Diabetic Footwear, and More

The world of home healthcare is rapidly evolving, with more and more people opting to manage their health from the comfort of their own homes. This shift is largely thanks to advancements in medical equipment and the rise of online shopping, which provides convenient access to essential healthcare products. Whether you’re managing a chronic condition, recovering from surgery, or simply looking for ways to improve your health and comfort, products like CPAP machines, diabetic footwear, and other home healthcare devices play a critical role in daily well-being.

In this blog, we’ll take a closer look at these popular categories of home healthcare equipment, their benefits, and why buying them online can be a game-changer for patients and caregivers alike.

1. CPAP Machines: A Lifesaver for Sleep Apnea Sufferers

Sleep apnea is a serious condition that causes frequent pauses in breathing during sleep. One of the most common types of sleep apnea, obstructive sleep apnea (OSA), occurs when the muscles in the back of the throat relax too much, blocking the airway. For individuals with sleep apnea, CPAP machines are often the prescribed treatment to help keep the airway open and allow for uninterrupted breathing during sleep.

Why CPAP Machines Are Essential:

Improved Sleep Quality: CPAP machines prevent the airway from collapsing, ensuring that oxygen levels remain stable throughout the night. This leads to better sleep quality, which is vital for overall health.

Reduced Risk of Complications: Untreated sleep apnea is linked to a host of complications, including high blood pressure, heart disease, stroke, and diabetes. Regular use of a CPAP machine helps mitigate these risks and improves cardiovascular health.

Enhanced Energy and Alertness: By improving sleep, CPAP machines help reduce daytime fatigue, allowing users to feel more alert, focused, and energized during the day.

The Convenience of Buying CPAP Machines Online:

Easy Access to Information: Online stores provide detailed descriptions, specifications, and customer reviews for CPAP machines and accessories. This allows you to make an informed decision based on your specific needs, whether you require a standard CPAP, auto-adjusting machine, or a BiPAP machine.

Wide Selection: With a variety of models available online, you can find the right CPAP machine, mask, and accessories to fit your lifestyle. Some online stores also offer bundled packages, which may include filters, masks, and tubing at discounted prices.

Convenient Shipping and Setup: Many online retailers offer free shipping, making it easier for you to receive your equipment directly at home. Some even offer remote setup assistance, ensuring that you’re able to use your CPAP machine correctly right away.

Insurance Compatibility: Many online stores work with insurance companies to help cover the cost of CPAP machines, which can be a significant expense. Be sure to check whether the retailer accepts your insurance plan and if your CPAP equipment is eligible for reimbursement.

2. The Role of Diabetic Footwear in Preventing Complications

People with diabetes face a higher risk of foot problems due to nerve damage (neuropathy) and poor circulation. This can lead to injuries, ulcers, infections, and in severe cases, amputations. Diabetic footwear is designed to protect the feet, reduce pressure, and promote healthy circulation, which is crucial for managing diabetes effectively.

Why Diabetic Footwear Is Important:

Prevents Foot Ulcers: Diabetic shoes are specially crafted to reduce pressure points, preventing the development of ulcers or blisters. Properly fitted shoes can also help with swollen feet and foot deformities common in diabetic patients.

Increased Comfort: Diabetic shoes are designed with extra cushioning and support to ensure comfort throughout the day. They often feature seamless linings to reduce friction and irritation.

Accommodates Foot Deformities: Many individuals with diabetes suffer from conditions like bunions, hammer toes, and Charcot foot, which can make wearing regular shoes difficult. Diabetic footwear is designed to accommodate these deformities and provide relief.

Buying Diabetic Footwear Online:

Access to a Wide Variety of Styles: Gone are the days when diabetic shoes were limited to unsightly options. Online stores now offer a wide selection of stylish and comfortable diabetic shoes that look great while providing the necessary support.

Custom Sizing and Fit: Many online retailers allow customers to enter foot measurements for a customized fit. This is essential for diabetic patients, as a poorly fitting shoe can lead to complications.

Insurance Coverage: In some cases, Medicare and other insurance plans may cover the cost of diabetic shoes. Online stores often provide the necessary documentation to help you file insurance claims for reimbursement.

Easy Returns and Exchanges: If the shoes you purchase don’t fit properly, most online retailers offer simple return and exchange policies, ensuring that you can find the perfect pair for your feet.

3. Exploring Other Essential Home Healthcare Equipment

In addition to CPAP machines and diabetic footwear, many other types of home healthcare equipment are available online, allowing patients to manage a wide range of medical conditions without leaving the house.

Common Home Healthcare Equipment You Can Buy Online:

Blood Pressure Monitors: Monitoring your blood pressure is crucial for managing conditions like hypertension or heart disease. Online stores offer a wide variety of automatic blood pressure cuffs that make it easy to track your health at home.

Oxygen Concentrators: For individuals with respiratory conditions such as COPD, emphysema, or asthma, oxygen concentrators are essential for ensuring they get the oxygen they need throughout the day. Online retailers offer both portable and stationary concentrators, so you can choose the one that fits your lifestyle.

Mobility Aids: Whether you need a walker, wheelchair, or scooter, online retailers offer a wide range of mobility aids to help improve mobility and independence. Many of these products are adjustable to accommodate different levels of need.

Incontinence Supplies: For individuals with incontinence, products like adult diapers, pads, and urinary catheters are essential. These supplies are often available in bulk online, offering cost savings and convenience.

Therapeutic Beds and Mattresses: Adjustable beds and medical mattresses are essential for individuals with limited mobility, chronic pain, or those recovering from surgery. Online retailers often offer a variety of options with features like pressure relief and adjustable settings to enhance comfort.

Benefits of Buying Home Healthcare Equipment Online:

Convenience and Accessibility: You can shop for a wide range of healthcare products at any time of the day, eliminating the need to visit physical stores. Online stores also offer quick delivery, so you can get the equipment you need without delay.

Broader Selection: Online retailers often have a broader selection of healthcare equipment, including products for specific conditions that might not be available locally.

Competitive Pricing: Many online stores offer discounts, free shipping, and bundle deals that can help you save on essential healthcare products. Shopping online also allows you to compare prices easily across multiple stores.

Insurance Support: Many online retailers accept insurance and help process claims, making it easier to get reimbursed for your medical supplies.

Conclusion: Empowering Patients Through Online Healthcare Shopping

The growing demand for home healthcare equipment has led to an increase in the availability of essential products like CPAP machines, diabetic footwear, and other healthcare devices. With the convenience of online shopping, patients can access a wide variety of products tailored to their specific needs, at competitive prices, and have them delivered directly to their doors.

By taking advantage of the vast selection and helpful features that online stores offer, you can improve your quality of life and manage chronic conditions more effectively. Whether you're dealing with sleep apnea, diabetes, or other medical concerns, online shopping for healthcare equipment provides convenience, affordability, and peace of mind.

When buying healthcare products online, always ensure that you're purchasing from a reputable retailer, that the product meets your specific needs, and that it aligns with any insurance coverage you have. With these tips in mind, you can confidently navigate the world of home healthcare equipment and make informed decisions that enhance your well-being.

[medoriscare]

As the festive season approaches, we know that finding the perfect gift for your #elderly loved ones—especially those who may be in a #carehome or #nursing home—can add a touch of joy and comfort to their days. Here at Medoriscare, a friendly, local manufacturing company right in your community, we understand the unique needs of the elderly, particularly those living with #Dementia, #mobility challenges, recovering from #injuries, or those in need of specialised care for conditions like #pressure #ulcers and #incontinence. Our range includes thoughtfully designed #adaptiveclothing, #pressurecarecushions, and high-quality #incontinence solutions such as pads and washable #bedpads . This #Christmas, why not show your loved ones how much you care by giving them a gift that not only brings them comfort but also supports their independence and #dignity? Choose a #gift from our selection, and let us take care of presenting it in beautiful, festive wrapping. Making your loved ones happy, comfortable, and cared for has never been easier. Remember, by choosing to shop with us, you're not just finding the perfect gift—you're also supporting a locally based small business, keeping the spirit of community alive and thriving. Shop now > www.medoriscare.com

[helen0086]

Liposomes Coenzyme Q10 Quality Evaluation

Liposomes are ultra-microscopic spherical carriers that encapsulate drugs in a lipid bilayer. They exert their effect by being released through osmosis or phagocytosis by macrophages [1]. Liposomes have a variety of characteristics as drug carriers. They can encapsulate both water-soluble and fat-soluble drugs. In particular, they have attracted much attention for their ability to improve the selectivity of drugs for target organs, reduce toxicity and increase the therapeutic index.

Coenzyme Q1O (coenzyme Q1O) is a coenzyme-type biochemical drug [2, 3] that is a major component of proton transfer and electron transfer in the respiratory chain of cells of living organisms. It is an activator of cellular metabolism and respiration. Coenzyme Q1O can improve mitochondrial respiratory function, promote oxidative phosphorylation, protect the integrity of the structure of biological membranes, and has a significant anti-radiation effect and 5α-reductase inhibitory effect.

It is often used in clinical practice to assist in the treatment of coronary heart disease, hypertension, congestive heart failure and arrhythmia, and also has significant effects on photosensitivity, skin ulcers, dermatitis, bedsores, trauma and other conditions. In recent years, it has also been widely used in the treatment of hair loss, pigmentation and the elimination of wrinkles to improve the quality of life. Coenzyme Q1O liposome is a newly developed pharmaceutical preparation in this laboratory, and this experiment studied the quality evaluation method.

Materials and Methods

1. 1 Instrument and Reagents

Experiments: pHS-3TC precision digital pH meter (Shanghai Tianda Instrument Co., Ltd.); CARY-1OO UV-Visible spectrophotometer (Varian, USA); high performance liquid chromatograph (Waters, USA): 51O high pressure constant current pump, 486 variable square wave length data UV detector; SR2OOO chromatography data workstation (Shanghai Sunrui Technology Co., Ltd.); TSM ultrafine particle size analyzer (Shanghai University of Technology); FA 1OO4 electronic balance (Shanghai Tianping Instrument Factory); 8O-2 centrifugal sedimentation machine (Shanghai Surgical Instrument Factory). Coenzyme Q1O raw material (Nisshin, Japan), the reference substance is refined from the raw material, purity 99.98%; Coenzyme Q1O liposome (homemade); blank liposome (homemade); anhydrous ethanol (China Pharmaceutical Group Shanghai Chemical Reagent Company); water is deionized distilled water; the remaining reagents are analytically pure.

2 pH Value Inspection

According to the 2OOO edition of the Pharmacopoeia of the People's Republic of China, Appendix VI H, a glass electrode is used as the indicator electrode and an acidimeter is used for measurement.

1. 3 Morphological Observation and Particle Size Distribution Measurement

Coenzyme Q1O liposomes were taken, stained with a negative staining method, and the morphology of the particles was observed under a transmission electron microscope; the particle size distribution was determined using a TMS ultrafine particle size analyzer.

1.4 Determination of Coenzyme Q1O Content by RP-HPLC

1. 4. 1 Chromatographic Conditions

DABC18RPODS column (15Omm× 4. 6 mm , 1Oμm, Shanghai Yiqi Technology Co., Ltd.); mobile phase: anhydrous ethanol; flow rate: 1. Oml/min; ultraviolet detection wavelength: 275nm, sensitivity: 0. O5 AuFS, injection volume 1Oμl, external standard method for quantification.

1.4. 2 Standard Curve and Detection Limit

A series of coenzyme Q1O solutions were prepared with anhydrous ethanol to give mass concentrations of 1. O, 2. O, 4. O, 8. O, and 16. O μg/ml, and detected by RP-HPLC.

1. 4. 3 Precision of the Method

Coenzyme Q1O standard solutions of 1. O, 2. O, 4. O, 8. O, and 16. O μg/ml were prepared, and the measurements were repeated 5 times within the day and between days.

4. 4 Sample Addition Recovery

Take an appropriate amount of empty liposomes, place them in a 1Oml volumetric flask, and measure precisely 25ml of coenzyme Q1O stock solution (O. 1g/ml) each. Shake well and determine the content according to the sample analysis method.

1. 4. 5 Sample Determination

Measure accurately an appropriate amount of coenzyme Q1O liposome, place it in a 1Oml volumetric flask, make up to the mark with absolute ethanol, shake well, and then dilute 1OO times with absolute ethanol. Shake well to obtain the test solution. Measure accurately 1Oμl of the test solution and inject it. Calculate the content of the test solution from the standard curve.

5 Determination of the Encapsulation Rate of Liposomes Coenzyme Q1

Dilute coenzyme Q1O liposomes 20 times with phosphate buffer (pH 7.4), measure an appropriate amount and place it in a centrifugal ultrafilter with a molecular weight cut-off of 5OOOO. Centrifuge at 3OOOr/min for 1O min to obtain a clear centrifugal liquid. Centrifuge the solution carefully, take an appropriate amount of the supernatant, dissolve it in anhydrous ethanol and make up to the mark. Shake well to obtain the test solution. Centrifuge a precise amount of 10 μl of the solution and calculate the free coenzyme Q10 content from the standard curve. Calculate the drug encapsulation rate according to the following formula:

where Wtotal and Wfree represent the total drug content and the free drug content in the liposome, respectively.

2 Results

1 Main Characteristics of Liposomes Coenzyme Q1O

Coenzyme Q1O liposomes are a pale yellow emulsion with a pH of 5. O~7. 5. They are mainly composed of unilamellar liposomes and a small amount of multilamellar liposomes. The particle sizes are relatively uniform and they are a colloidal colloidal dispersion; the particle size is basically normally distributed, with an average particle size of 0.184 μm and particles > 1 μm accounting for 0.17%.

2. 2 Results of RP-HPLC Analysis

2. 2. 1 Standard Curve Regression of Peak Area (A) Against Concentration (C) Gives the Standard Curve:

C= 6. 974× 1O— 5A—5. 894× 1O— 2, r = O. 9999(n=5)

The results show that the concentration in the range of 1. O~16. Oμg/ml has a good linear relationship with the peak area. The lowest detectable concentration of the method is 0. 1μg/ml, the lowest detection limit is 1ng, the retention time of coenzyme Q1O is about 4. 4min, and the theoretical plate number is more than 3OOO.

2. 2 Method Precision and Recovery

Intraday and interday RSD<2%. The average recovery rate was (1OO. 5±O. 65)%, n = 3.

2.2. 3 Sample Measurement Results

Three batches of samples were measured, and the coenzyme Q1O content in coenzyme Q1O liposomes was 94. 71%, 1O3.46% and 91. O9% of the labeled amount, respectively, all within the range of 9O. O%~11O. O% specified in the quality standard.

2.3 Encapsulation Rate of Liposomes Coenzyme Q10 

The encapsulation rate of three batches of coenzyme Q1O liposome samples was measured, and the encapsulation rate was >95%, which meets the requirements of liposome quality control.

3 Discussion

At present, the main methods used at home and abroad for ultrafine particle size analysis include optical microscopy, light transmission, laser scattering, and specific gravity methods. The TSM ultrafine particle size analyzer used in this experiment is a new type of particle size analyzer based on the principle of total light scattering [4]. It is used to measure the size distribution of ultrafine particles to meet the requirements of particle detection and size analysis.

A solution of coenzyme Q1O in absolute ethanol of a certain concentration was scanned with UV light in the wavelength range of 19O~ 35Onm. It was shown that coenzyme Q1O has a large absorption at 2O4, 275nm. Since there is interference in the measurement at 2O4nm, 275 nm was selected as the measurement wavelength in this experiment.

Literature reports [1] that there are many methods for determining the encapsulation rate, mainly including the dextran gel filtration method, ultracentrifugation method, dialysis method, etc. The dextran gel filtration method is a classic determination method, but it is cumbersome, time-consuming, and the raw materials are also more expensive; the ultracentrifugation method requires high instrument conditions and is expensive; the dialysis method requires continuous replacement of the dialysis solution. In this experiment, a centrifugal ultrafilter was used to determine the encapsulation rate. Coenzyme Q1O phosphate buffer can completely pass through the filter membrane. This method is convenient, fast, easy to operate, and has good reproducibility, making it more suitable for quality control in the production process.

Coenzyme Q10 is easily decomposed by light. Formulating it as a liposome preparation can improve the stability of the drug and prolong its duration of action. In addition, liposomes are hydrophilic carriers composed of phospholipid bilayers, which can also increase the compatibility of coenzyme Q10 with other hydrophilic components and increase its absorption in the body.

References:

[1] Gao Shen, ed. New dosage forms and technologies for modern drugs [M]. Beijing: People's Military Medical Publishing House, 2OO2. 197-228.

[2] Greenberg S, Frishman WH. Coenzyme Q1O: a new drug for cardiovascular disease [J]. J Clin Pharmacol, 199O, 3O(7) : 596- 6O8.

[3] Hoppe U, Bergemann j , Diembeck W , et al. Coenzyme Q1O, a cutaneous antioxidant and energizer[j]. Biofactors, 1999, 9(2- 4): 371-378.

[4] Cai XS. Measurement of particle size distribution with light extinction method [J]. Guangxue xuebao (Acta optica sin), 1991, 11(11): 49-53.

[scotianostra]

The Scottish physician and inventor Neil Arnott was born on May 15th 1788.

Arnott, was born in the town of Arbroath, he  would become a very highly-regarded physician and show an inventiveness unusual for his era.

Misfortunes compelled the father, Alexander, to give up his farm and settle first at Blair and afterwards in Aberdeen. Neil was taught by his mother Ann, and at the parish school of Lunan, and in November 1798 entered Aberdeen grammar school. In 1801 he was entered as a student in the Marischal College, with a small bursary, where he remained during four sessions, and was especially interested by the lectures of Patrick Copland on natural philosophy. He graduated M.A. in 1805, and at once commenced the study of medicine in Aberdeen. He supported himself partly by acting as shop-assistant to a chemist.

By the age of 19 young Neil was a fully fledged surgeon and made two visits to China as surgeon for the British East India Company and then settled in London where his reputation would grow and grow.

He gave lectures at the Philomathic Institution and published these as Elements of physics. Arnott was one of the founders of the University of London, 1836. Within a few years he was made physician to the French and Spanish embassies, and in 1837 he became physician extraordinary to the Queen. He was elected to the Fellow of the Royal Society in 1838. He was a strong advocate of scientific, as opposed to purely classical, education.

Doctor Arnott gifted 2,000 pounds to each of the four universities of Scotland and to the University of London, to promote its study in the experimental and practical form.Of his inventions they included, a  Smokeless Fire-place, Chimney-valves, and “Other Means, Old and New of obtaining Healthful warmth and ventilation”  But is the final invention I find most interesting, he gave us the first form of waterbed. Dr Arnott’s Hydrostatic Bed, as it was known, had been created to help invalids avoid bedsores. A bath of water covered with rubber-impregnated canvas, and a lighter bedding on top, it worked a treat. The modest Arnott, however, didn’t choose to patent the idea, amazingly the waterbed was not actually patented until 1968 by an American furniture designer Charles Prior Hall, but oor Dr Arnott definitely came up with the idea first.

The water bed was first used in aid of medicine. In 1873, when Sir James Paget at St Bartholomew’s Hospital presented a waterbed designed by Arnott as a treatment and prevention of pressure ulcers (bed sores); a condition that was quite common in this era. Paget found that waterbeds allowed mattress pressure to be evenly distributed over the body. Unfortunately, this invention lacked the ability to regulate the temperature of the water.

And so we have another first from a Scot, the waterbed!

Neil Arnott died in London in 1874 but is buried with his mother in Dean Cemetery in Edinburgh.

[medicaldevicess]

Wound Dressing Market: A Deep Dive into a Growing Sector

The wound dressing market is dynamic and always changing as a result of growth in medical technology and augmentation of healthcare expenditure across the world. This market holds an array of products focusing on healing various types of wounds, from minor cuts to chronic ulcers.

The wound dressing market size is projected to reach US$ 19.69 billion by 2031 from US$ 11.99 billion in 2023. The market is expected to register a CAGR of 6.4% during 2023–2031.  Market Trends

Growing factors in the market of wound dressing include:

The geriatric population is more prone to chronic wounds like diabetic ulcers and pressure ulcers, requiring specific wound dressings for proper management.

The incidence of chronic diseases such as diabetes, obesity, and cardiovascular diseases leads to the formation of chronic wounds and hence creates a demand for advanced wound care solutions.

New Age in Wound Care Technology: Advancement in improved properties of wound dressings such as antimicrobial, moisture-retentive and pain-relieving is growing market.

Healthcare expenditure rising: Rising healthcare expenditure all over the world, especially emerging economies is helping to create higher demand for advanced wound care products.

Market Segment 

By Type

Advanced Wound Dressing

Traditional Wound Dressing

By Application

Chronic Wound

Acute Wound

By End User

Hospitals

Ambulatory Surgical Centers

Clinics

By Region

North America

Europe

Asia-Pacific

South and Central America

Middle East and Africa

Key Players

Convatec Inc

Coloplast Corp

3M

Medline Industries Inc

Medtronic

Integra Lifesciences Corporation

Axio Biosolutions Pvt Ltd

Advancis Medical USA LLC

Smithnephew PLC

M lnlycke Healcare AB

Future Outlook

The future of the wound dressing market appears bright with many trends driving it ahead:

Advanced Wound Care: Advanced wound care techniques and products are gaining momentum, such as regenerative medicine and tissue engineering.

Personalized Medicine: Personalized wound care solutions are being developed based on individual patient needs.

It would integrate digital health technologies in, for example, the form of smart wound dressings or remote monitoring systems.

The wound dressing market is expected to rise drastically in the coming years. Various factors, such as demographic changes, increasing prevalence of chronic diseases, and improved technology, are on the table. The companies are focusing on innovation, product differentiation, and strategic partnerships to take hold of new opportunities and sustain their lead.

Frequently Asked Questions-

Which is the largest regional market for Wound Dressing?

Ans: - The biggest regional market for Wound Dressing is North America.

Who are the prominent companies that hold the market share in the Wound Dressing market?

Ans: - The leading companies holding the market share are Convatec Inc., Coloplast Corp, 3M, Medline Industries, Inc., Medtronic, Integra Lifesciences Corporation, and Axio Biosolutions Pvt. Ltd, Advancis Medical USA LLC, Smithnephew PLC, and Mölnlycke Healthcare.

What will be the growth rate at which the market is expected to grow during the forecast period of 2023 to 2031?

Ans: - The Wound Dressing market is expected to record 6.4% growth in the forecast period.

How large is the Wound Dressing market?

Ans: The global Wound Dressing market size was valued at US$ 11.99 billion in 2023 and is anticipated to reach US$ 19.69 billion by 2031.

Which are the segments of the Wound Dressing market?

Ans: - The Wound Dressing market is segmented into Type, Application, End User, and region.

About Us-

The Insight Partners is among the leading market research and consulting firms in the world. We take pride in delivering exclusive reports and sophisticated strategic and tactical insights into the industry. Reports are generated through a combination of primary and secondary research, solely aimed at giving our clientele a knowledge-based insight into the market and domain. This is done to assist clients in making wiser business decisions. A holistic perspective in every study undertaken forms an integral part of our research methodology and makes the report unique and reliable.

[health-views-updates]

Wound Care Devices Market 2024 Size, Share, Feasibility Status and Growth Outlook by 2032

The global wound care devices market is projected to experience significant growth over the next several years, driven by increasing incidences of chronic diseases, advancements in healthcare infrastructure, and rising demand for innovative wound management solutions. The latest report from SNS Insider sheds light on key trends, opportunities, and growth drivers within the Wound Care Devices Market Revenue, offering a comprehensive overview for industry stakeholders.

Chronic wounds, such as diabetic ulcers, pressure ulcers, and venous leg ulcers, are increasingly common worldwide, resulting from rising diabetes and obesity rates, coupled with an aging population. In response, healthcare providers are prioritizing advanced wound care solutions that ensure faster healing and reduced hospitalization time. The wound care devices market encompasses a variety of innovative products, including negative pressure wound therapy (NPWT), wound closure devices, and tissue repair solutions, all tailored to address specific clinical needs. These advancements aim to enhance patient outcomes, minimize infection risks, and optimize healthcare costs for providers and patients alike.

Emerging economies in the Asia-Pacific and Latin American regions are showing robust market potential due to rising healthcare expenditures and improved accessibility to advanced wound care products. Additionally, manufacturers in the wound care devices market are investing heavily in research and development, striving to introduce cutting-edge solutions that cater to unmet clinical needs. Notably, the incorporation of artificial intelligence, machine learning, and other digital health technologies in wound care management is expected to reshape the industry landscape, further fueling market expansion.

Get Free Sample Report@ https://www.snsinsider.com/sample-request/3237

Key Trends Driving Market Growth

1. Technological Advancements in Wound Care Devices Technological innovation plays a critical role in revolutionizing wound care management. Devices equipped with smart sensors, for instance, monitor wound conditions in real-time, enabling healthcare professionals to make data-driven treatment adjustments. Smart wound dressings with antimicrobial properties and moisture control have also gained traction, reducing the risk of infection and facilitating faster recovery. Furthermore, developments in telemedicine are making remote wound care consultations more accessible, particularly in rural and underserved areas.

2. Government Support and Healthcare Policies Governments around the world are increasingly recognizing the importance of advanced wound care in managing chronic wounds. This recognition is reflected in favorable policies and funding aimed at making wound care devices more accessible to healthcare providers. The growing emphasis on reducing healthcare costs and improving patient outcomes aligns well with the benefits that advanced wound care devices offer. Moreover, favorable reimbursement policies in developed countries are encouraging hospitals and clinics to adopt advanced wound care devices, further driving market demand.

3. Rising Prevalence of Chronic Diseases and Geriatric Population Chronic diseases, such as diabetes and cardiovascular conditions, are on the rise globally, and the aging population is expanding rapidly. This demographic shift leads to a higher incidence of chronic wounds, which require advanced treatment. With a growing elderly population prone to slow-healing wounds, the demand for sophisticated wound care devices is likely to surge. In response, companies in the wound care devices market are focusing on creating products specifically designed for geriatric patients, who are at greater risk for complications during wound healing.

Competitive Landscape and Future Prospects

The wound care devices market is characterized by a highly competitive landscape, with major players consistently striving to introduce innovative products. Leading companies are entering strategic partnerships, mergers, and acquisitions to expand their product portfolios and global reach. Some prominent players are also investing in collaborations with research institutions and universities to drive product development and maintain a competitive edge.

The market is expected to experience sustained growth, with a focus on precision wound care solutions that allow for customized treatment approaches. The integration of robotics and automation in wound care devices presents new possibilities for the market, offering improved accuracy in treatment and wound management.

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us: Akash Anand – Head of Business Development & Strategy Email: info@snsinsider.com Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

[farmacuticals]

The Future of Wound Care: The Rise of Anti-Biofilm Dressing Technologies

Anti biofilm wound dressing is a specialized form of dressing designed to prevent or disrupt biofilm formation on wounds. Biofilms are colonies of bacteria that adhere to wound surfaces, often creating a slimy layer that can resist antibiotics and the immune response. These biofilms can prolong infection, hinder healing, and lead to chronic wounds. Anti biofilm wound dressings aim to reduce or eliminate biofilm presence through antimicrobial agents, physical disruption, or chemical means. This innovative approach is gaining attention, especially for patients with chronic wounds such as diabetic ulcers, pressure ulcers, and other non-healing wounds.

According to MRFR analysis, the market for anti-biofilm wound dressings was projected to be worth 1.92 billion USD in 2022. It is anticipated that the market for anti-biofilm wound dressings would increase from 2.05 billion USD in 2023 to 3.74 billion USD in 2032. The Anti Biofilm Wound Dressing Market is anticipated to develop at a compound annual growth rate (CAGR) of approximately 6.9% from 2024 to 2032.

Anti Biofilm Wound Dressing Market Size

The market for anti biofilm wound dressing has grown rapidly due to the increasing need for effective wound care solutions, especially for those prone to biofilm-related infections. The market size is anticipated to expand as more healthcare providers, hospitals, and clinics adopt these dressings as a standard for chronic wound management. Factors driving this growth include the rising prevalence of chronic diseases like diabetes and obesity, aging populations, and the demand for advanced wound care technologies. In recent years, the market has seen an influx of new products with enhanced biofilm-resistant properties, further contributing to its expansion.

Anti Biofilm Wound Dressing Share

Anti biofilm wound dressing has become a significant segment within the wound care industry, as it targets a crucial aspect of wound management that traditional dressings often overlook. Companies specializing in wound care, as well as newer entrants, are heavily investing in research and development to capture market share. In hospitals and home healthcare settings, the use of anti biofilm wound dressing is increasingly preferred due to its impact on improving wound healing outcomes. Many companies have diversified their product offerings with anti biofilm features, and as a result, this segment now holds a substantial share of the wound care market.

Anti Biofilm Wound Dressing Analysis

The analysis of the anti biofilm wound dressing market reveals several key trends. Firstly, there is a shift toward using more sustainable, biocompatible materials in dressings to reduce adverse reactions in patients. Secondly, there is a trend toward integrating biofilm-targeting agents within dressings to allow sustained release over time, which has proven to be effective in reducing biofilm formation. Additionally, recent technological advancements in diagnostics allow clinicians to better detect and treat biofilms, supporting the effectiveness of anti biofilm wound dressing. With advancements in material science and biochemistry, companies are continually innovating to improve efficacy, thus creating competitive advantages.

Anti Biofilm Wound Dressing Trends

Several trends are shaping the future of anti biofilm wound dressing:

Biodegradable Dressings: Manufacturers are focusing on eco-friendly, biodegradable options to reduce environmental impact.

Nanotechnology: Incorporation of nanotechnology in wound dressings has shown promising results in inhibiting biofilm formation and enhancing healing.

Increased Homecare Usage: With an increasing number of patients opting for at-home wound care, demand for easy-to-use and effective anti biofilm wound dressing is rising.

Personalized Treatments: Customized dressings tailored to individual patients' needs are emerging, improving outcomes for those with complex or chronic wounds.

Integration with Digital Health: Smart dressings that monitor wound healing progress and alert healthcare providers about biofilm presence are gaining popularity.

Reasons to Buy Anti Biofilm Wound Dressing Reports

In-depth market analysis provides valuable insights into current and emerging trends, giving companies a competitive edge.

Detailed information on market size, share, and segmentation helps investors and stakeholders make informed decisions.

Analysis of key players and their strategies aids in understanding competitive dynamics.

Insights into recent technological advancements provide knowledge of new product developments and innovation trends.

Forecasts and future outlook offer guidance for strategic planning and long-term investments.

Recent Developments in Anti Biofilm Wound Dressing

Recent innovations include the development of dressings that incorporate slow-release antimicrobial agents, advanced polymer technology for biofilm prevention, and dressings that combine anti-inflammatory properties with biofilm disruption. Companies are also working on integrating biosensors within the dressing to detect infection markers, allowing early intervention. Additionally, recent FDA approvals and clinical trials are expanding access to cutting-edge anti biofilm wound dressing products. With these developments, the anti biofilm wound dressing market is poised for sustained growth as healthcare providers adopt advanced solutions for better patient outcomes.

Related reports:

colonoscope market

d mannose market

contrast injector market

cryo electron microscopy market

Top of Form

Bottom of Form

[jayanthitbrc]

Hyperbaric Oxygen Therapy Devices Market Outlook 2024-2033: Trends and Projections

The hyperbaric oxygen therapy devices global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Hyperbaric Oxygen Therapy Devices Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The hyperbaric oxygen therapy devices market size has grown strongly in recent years. It will grow from $3.82 billion in 2023 to $4.19 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing prevalence of chronic wounds, diabetic ulcers, and other conditions, rising adoption of hyperbaric oxygen therapy (HBOT) for treating decompression sickness, growing awareness about the therapeutic benefits of HBOT for neurological disorders, expansion of healthcare infrastructure, and rising government initiatives and funding programs promoting research and development.

The hyperbaric oxygen therapy devices market size is expected to see strong growth in the next few years. It will grow to $6.11 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to a growing aging population, growing incidence of diabetes, increasing investment in research and clinical trials to explore new indications and optimize HBOT protocols, growing demand for portable and transportable hyperbaric chambers, and rising healthcare expenditure and insurance coverage for HBOT. Major trends in the forecast period include integration of artificial intelligence (AI) and machine learning algorithms, development of hyperbaric oxygen therapy apps and software platforms, adoption of hyperbaric oxygen therapy in combination with other regenerative medicine modalities, introduction of wearable hyperbaric oxygen devices, and use of hyperbaric chambers in sports performance optimization and recovery programs for athletes, coaches, and fitness enthusiasts.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/hyperbaric-oxygen-therapy-devices-global-market-report

Scope Of Hyperbaric Oxygen Therapy Devices MarketThe Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Hyperbaric Oxygen Therapy Devices Market Overview

Market Drivers -The rise in diabetes prevalence is expected to propel the growth of the hyperbaric oxygen therapy device market going forward. Diabetes refers to a group of chronic metabolic disorders characterized by high blood sugar levels over a prolonged period of time. The diabetes cases are on rise due to sedentary lifestyles, unhealthy dietary habits, obesity, genetic predispositions, aging populations, urbanization, and socioeconomic factors. Hyperbaric oxygen therapy devices offer a complementary approach to managing diabetes by facilitating wound healing and tissue repair through the delivery of high-pressure oxygen, thereby potentially reducing the risk of complications such as diabetic foot ulcers and improving overall outcomes for individuals with diabetes. For instance, in June 2023, according to the data published by the Institute for Health Metrics and Evaluation (IHME), a US-based independent population health research center, global diabetes cases are expected to surge from 529 million in 2023 to 1.3 billion by 2050. The global prevalence rate at 6.1%, is projected to rise dramatically. At the super-region level, the highest prevalence rate, currently at 9.3% in North Africa and the Middle East, is forecasted to increase to 16.8% by 2050. Therefore, a rise in diabetes prevalence is driving the hyperbaric oxygen therapy device market.

Market Trends - Major companies operating in the hyperbaric oxygen therapy device market are developing integrating automated logging software into hyperbaric chambers to enhance treatment accuracy, efficiency, and patient care. Integrating automated logging software into hyperbaric chambers helps healthcare professionals accurately capture and monitor treatment parameters in real-time, ensuring precise documentation, streamlined reporting, and enhanced patient safety throughout hyperbaric therapy sessions. For instance, in January 2024, Sechrist Industries Inc., a US-based manufacturer of hyperbaric oxygen chambers and respiratory equipment, launched the 3300 HM Hyperbaric Chamber and the eHEAL System. The 3300 HM Hyperbaric Chamber prioritizes patient comfort and safety with its modern design and innovative Patient Step-in Entry, eliminating the need for a hyperbaric stretcher. Enhanced safety features, user-friendly breathing systems, and versatile compression options cater to diverse medical needs. Meanwhile, the eHEAL System streamlines hyperbaric treatment logging with its intuitive interface, automated data capture, multi-chamber connectivity, and comprehensive logging capabilities. It ensures accuracy, efficiency, and security in treatment records, offering seamless integration with existing systems.

The hyperbaric oxygen therapy devices market covered in this report is segmented –

1) By Type: Monoplace Hyperbaric Oxygen Therapy Devices, Multiplace Hyperbaric Oxygen Therapy Devices, Topical Hyperbaric Oxygen Therapy Devices 2) By Application: Wound Healing, Decompression Sickness, Infection Treatment, Gas Embolism, Other Applications 3) By End User: Hospitals, Home Care, Other End Users

Get an inside scoop of the hyperbaric oxygen therapy devices market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15589&type=smp

Regional Insights - North America was the largest region in the hyperbaric oxygen therapy devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperbaric oxygen therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies - Major companies operating in the hyperbaric oxygen therapy devices market are Healogics LLC, SOS Medical Group Ltd., Environmental Tectonics Corporation, Sechrist Industries Inc., BioBarica, Perry Baromedical Corporation, Shanghai Baobang Medical Equipment, Hyperbaric Modular Systems Inc., BAROKS Hyperbaric, HAUX-LIFE-SUPPORT GmbH, Hyperbaric SAC, Pan America Hyperbarics Inc., AHA Hyperbarics, Fink Engineering Pty Ltd, Gulf Coast Hyperbarics, Hyperbaric Medical Solutions, NHC Medical And Beauty, OxyHeal Health Group, Royal IHC, The Oxybarica Group, Hpotech Medical Solutions, Jiangsu Haila Resuscitation Equipment Co. Ltd., OxyHelp Industry SRL, Oxyvein Hyperbaric Chambers, HBOT Medical

Table of Contents 1. Executive Summary 2. Hyperbaric Oxygen Therapy Devices Market Report Structure 3. Hyperbaric Oxygen Therapy Devices Market Trends And Strategies 4. Hyperbaric Oxygen Therapy Devices Market – Macro Economic Scenario 5. Hyperbaric Oxygen Therapy Devices Market Size And Growth ….. 27. Hyperbaric Oxygen Therapy Devices Market Competitor Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info

Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model